Protease inhibitors and the new AIDS combination therapies: Implications for psychological services

被引:32
作者
Kalichman, SC
Ramachandran, B
Ostrow, D
机构
[1] Med Coll Wisconsin, Ctr AIDS Intervent Res, Milwaukee, WI 53226 USA
[2] Georgia State Univ, Atlanta, GA 30303 USA
[3] Howard Brown Hlth Clin, Chicago, IL USA
关键词
D O I
10.1037/0735-7028.29.4.349
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Practicing psychologists face many challenges in caring for people living with HIV infection, including keeping abreast of new treatments and their impact on the psyche. Highly active antiretroviral therapies, which include protease inhibitors, demand particularly strict adherence to cumbersome treatment regimens, potentially interact with psychotropic medications, are not universally accessible, and may lower vigilance against AIDS. The promises of new treatments are also not always realized, and treatment failures pose significant psychological ramifications. In keeping pace with the ever-changing AIDS epidemic, psychologists and counselors should be aware of the promises and the realities of advances in medical treatments for HIV infection.
引用
收藏
页码:349 / 356
页数:8
相关论文
共 46 条
[11]   PRIMARY CARE PHYSICIANS AND AIDS - ATTITUDINAL AND STRUCTURAL BARRIERS TO CARE [J].
GERBERT, B ;
MAGUIRE, BT ;
BLEECKER, T ;
COATES, TJ ;
MCPHEE, SJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (20) :2837-2842
[12]   The role of immunologic and viral markers in predicting clinical outcome in HIV infection [J].
Graham, NMH .
AIDS, 1996, 10 :S21-S25
[13]   A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less [J].
Hammer, SM ;
Squires, KE ;
Hughes, MD ;
Grimes, JM ;
Demeter, LM ;
Currier, JS ;
Eron, JJ ;
Feinberg, JE ;
Balfour, HH ;
Dayton, LR ;
Chodakewitz, JA ;
Fischl, MA .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (11) :725-733
[14]  
HELLINGER FJ, 1993, HEALTH SERV RES, V28, P543
[15]   THE LIFETIME COST OF TREATING A PERSON WITH HIV [J].
HELLINGER, FJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (04) :474-478
[16]  
Ho DD, 1996, B NEW YORK ACAD MED, V73, P37
[17]   TIME TO HIT HIV, EARLY AND HARD [J].
HO, DD .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (07) :450-451
[18]  
Kalichman SC, 1997, PROF PSYCHOL-RES PR, V28, P355
[19]  
KALICHMAN SC, HLTH PSYCHOL
[20]   The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter [J].
Katzenstein, DA ;
Hammer, SM ;
Hughes, MD ;
Gundacker, H ;
Jackson, JB ;
Fiscus, S ;
Rasheed, S ;
Elbeik, T ;
Reichman, R ;
Japour, A ;
Merigan, TC ;
Hirsch, MS .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (15) :1091-1098